GED-0507 is a novel potential antifibrotic treatment option for pulmonary fibrosis

Cell Mol Immunol. 2020 Dec;17(12):1272-1274. doi: 10.1038/s41423-020-0394-y. Epub 2020 Mar 12.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aniline Compounds / administration & dosage
  • Aniline Compounds / therapeutic use*
  • Animals
  • Antifibrotic Agents / administration & dosage
  • Antifibrotic Agents / therapeutic use*
  • Disease Models, Animal
  • Mice
  • PPAR gamma / metabolism
  • Propionates / administration & dosage
  • Propionates / therapeutic use*
  • Pulmonary Fibrosis / chemically induced
  • Pulmonary Fibrosis / drug therapy*
  • Pulmonary Fibrosis / prevention & control

Substances

  • Aniline Compounds
  • Antifibrotic Agents
  • GED-0507
  • PPAR gamma
  • Propionates